Positive results from Phase 2 Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) Study SmartNews
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update Life Science Investing News
Medtronic to announce financial results for its first quarter of fiscal year 2025 Life Science Investing News
Medtronic announces FDA approval of Simplera CGM and global partnership with Abbott Life Science Investing News
The Pharmacology of Human Decision Making Study with Monash University Artificial Intelligence Investing
Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call Life Science Investing News
Medtronic: An Engineer and the Earthworms That Revolutionized Spinal Cord Stimulation Life Science Investing News
